Kazia Therapeutics (KZIA) Other Operating Expenses (2009 - 2011)
Kazia Therapeutics (KZIA) posted Other Operating Expenses of -$3.1 million for Q4 2011, down 11856.13% on a QoQ basis from $26359.6 in Q4 2009.
Kazia Therapeutics (KZIA) Other Operating Expenses (2009 - 2011) Analysis & Trends
Kazia Therapeutics' Other Operating Expenses history runs 2 years deep, the most recent figure standing at -$3.1 million for Q4 2011.
- Quarterly Other Operating Expenses changed N/A year-over-year to -$3.1 million in Q4 2011, while the trailing twelve-month figure through Dec 2012 was -$3.1 million (changed 0.0% YoY) and the FY2022 annual result came in at -$18.1 million, down 17.04% from the prior year.
- Other Operating Expenses was -$3.1 million for Q4 2011 at Kazia Therapeutics, down from $26359.6 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $26359.6 in Q4 2009 and bottomed at -$3.1 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -3.10 Mn |
| Dec 31, 2009 | 26,359.61 |